Radnor Capital Management, LLC Novartis Ag Transaction History

Radnor Capital Management, LLC

  • $627 Million
  • Q2 2025

A detailed history of Radnor Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Radnor Capital Management, LLC holds 5,725 shares of NVS stock, worth $739,212. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,725
Previous 5,450 5.05%
Holding current value
$739,212
Previous $608,000 13.98%
% of portfolio
0.11%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025
BUY
$101.96 - $121.01 $28,039 - $33,277
275 Added 5.05%
5,725 $693,000
Q4 2024

Jan 14, 2025
BUY
$96.78 - $117.18 $527,451 - $638,631
5,450 New
5,450 $530,000
Q3 2024

Oct 30, 2024
BUY
$106.13 - $120.89 $63,678 - $72,534
600 Added 10.13%
6,525 $751,000
Q1 2024

Apr 11, 2024
SELL
$95.27 - $108.47 $28,581 - $32,541
-300 Reduced 4.82%
5,925 $573,000
Q4 2023

Jan 11, 2024
SELL
$92.27 - $101.54 $13,840 - $15,231
-150 Reduced 2.35%
6,225 $629,000
Q3 2023

Oct 12, 2023
SELL
$94.73 - $105.13 $28,419 - $31,539
-300 Reduced 4.49%
6,375 $649,000
Q2 2023

Jul 07, 2023
BUY
$92.52 - $104.91 $617,571 - $700,274
6,675 New
6,675 $674,000
Q4 2022

Jan 09, 2023
SELL
$75.55 - $92.52 $39,286 - $48,110
-520 Reduced 7.08%
6,825 $623,000
Q3 2022

Oct 12, 2022
BUY
$74.61 - $87.26 $22,383 - $26,178
300 Added 4.26%
7,345 $558,000
Q1 2022

Apr 25, 2022
SELL
$80.11 - $90.62 $68,093 - $77,027
-850 Reduced 10.77%
7,045 $618,000
Q4 2021

Jan 20, 2022
SELL
$79.7 - $88.13 $129,911 - $143,651
-1,630 Reduced 17.11%
7,895 $691,000
Q1 2021

Apr 26, 2021
SELL
$83.5 - $98.47 $54,275 - $64,005
-650 Reduced 6.39%
9,525 $814,000
Q4 2020

Jan 13, 2021
BUY
$78.07 - $94.43 $3,903 - $4,721
50 Added 0.49%
10,175 $961,000
Q3 2020

Nov 02, 2020
SELL
$82.14 - $91.0 $16,428 - $18,200
-200 Reduced 1.94%
10,125 $880,000
Q3 2018

Oct 04, 2018
BUY
$66.94 - $77.43 $3,347 - $3,871
50 Added 0.49%
10,325 $890,000
Q1 2018

Apr 20, 2018
SELL
$70.39 - $84.15 $49,273 - $58,905
-700 Reduced 6.38%
10,275 $831,000
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $18,082 - $19,410
250 Added 2.33%
10,975 $921,000
Q2 2017

Aug 09, 2017
BUY
N/A
10,725
10,725 $895,000

Others Institutions Holding NVS

# of Institutions
1,558
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $278B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email